IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 30, Issue 25, 2012, Pages 3100-3108

  Moorman, Anthony V ^a   Schwab, Claire ^a   Ensor, Hannah M ^a   Russell, Lisa J ^a   Morrison, Heather ^a   Jones, Lisa ^a   Masic, Dino ^a   Patel, Bella ^b   Rowe, Jacob M ^d   Tallman, Martin ^e   Goldstone, Anthony H ^c   Fielding, Adele K ^b   Harrison, Christine J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONTROLLED STUDY; CRLF2 GENE; CYTOGENETICS; EVENT FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIVARIATE ANALYSIS; MUTATION; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MULTIVARIATE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CYTOKINE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865745212     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.3907     Document Type: Article

References (42)

1. Moorman AV, Harrison CJ, Buck GA, et al: Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial. Blood 109:3189-3197, 2007
2. Pullarkat V, Slovak ML, Kopecky KJ, et al: Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: Results of Southwest Oncology Group 9400 study. Blood 111:2563-2572, 2008
3. Bassan R, Hoelzer D: Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 29:532-543, 2011
4. Rowe JM: Optimal management of adults with ALL. Br J Haematol 144:468-483, 2009
5. Russell LJ, De Castro DG, Griffiths M, et al: A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia 23:614-617, 2009
6. Russell LJ, Capasso M, Vater I, et al: Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 114:2688-2698, 2009
7. Russell LJ, Akasaka T, Majid A, et al: t(6;14)(p22;q32): A new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 111:387-391, 2008
8. Akasaka T, Balasas T, Russell LJ, et al: Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109:3451-3461, 2007
9. Chapiro E, Russell L, Radford-Weiss I, et al: Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 108:3560-3563, 2006
10. Chapiro E, Russell LJ, Struski S, et al: A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 24:1362-1364, 2010
11. Chapiro E, Russell L, Lainey E, et al: Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia 24:642-645, 2010
12. Hertzberg L, Vendramini E, Ganmore I, et al: Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: A report from the International BFM Study Group. Blood 115:1006-1017, 2010
13. Mullighan CG, Collins-Underwood JR, Phillips LA, et al: Rearrangement of CRLF2 in B-progenitorand Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 41:1243-1246, 2009
14. Dyer MJ, Akasaka T, Capasso M, et al: Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: Rare clinical curios or potent genetic drivers? Blood 115:1490-1499, 2010
15. Mullighan CG, Goorha S, Radtke I, et al: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764, 2007
16. Strefford JC, Worley H, Barber K, et al: Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 26:4306-4318, 2007
17. Kawamata N, Ogawa S, Zimmermann M, et al: Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111:776-784, 2008
18. Mullighan CG, Su X, Zhang J, et al: Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360:470-480, 2009
19. Mullighan CG, Miller CB, Radtke I, et al: BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453:110-114, 2008
20. Ensor HM, Schwab C, Russell LJ, et al: Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and a CRLF2 deregulation: Results from the MRC ALL97 clinical trial. Blood 117:2129-2136, 2011
21. Cario G, Zimmermann M, Romey R, et al: Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood 115:5393-5397, 2010
22. Harvey RC, Mullighan CG, Chen IM, et al: Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 115:5312-5321, 2010
23. Kuiper RP, Waanders E, van der Velden VH, et al: IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24:1258-1264, 2010
24. Goldstone AH, Richards SM, Lazarus HM, et al: In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 111:1827-1833, 2008
25. Schwab CJ, Jones LR, Morrison H, et al: Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 49:1104-1113, 2010
26. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526, 1994
27. Litzow MR, Buck G, Dewald G, et al: Outcome of 1,229 adult Philadelphia chromosome negative B acute lymphoblastic leukemia (B-ALL) patients (pts) from the International UKALLXII/E2993 Trial: No difference in results between B cell immunophenotypic subgroups. Blood 116:232, 2010 (abstr 524)
28. Iacobucci I, Lonetti A, Messa F, et al: Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance. Blood 112:3847-3855, 2008
29. Familiades J, Bousquet M, Lafage-Pochitaloff M, et al: PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: A GRAALL study. Leukemia 23:1989-1998, 2009
30. Rowe JM, Buck G, Burnett AK, et al: Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 106:3760-3767, 2005
31. Yoda A, Yoda Y, Chiaretti S, et al: Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 107:252-257, 2010
32. Waanders E, van der Velden VH, van der Schoot CE, et al: Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts79%of relapses in pediatric acute lymphoblastic leukemia. Leukemia 25:254-258, 2011
33. Martinelli G, Iacobucci I, Storlazzi CT, et al: IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report. J Clin Oncol 27:5202-5207, 2009
34. Paulsson K, Cazier JB, Macdougall F, et al: Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci U S A 105:6708-6713, 2008
35. Iacobucci I, Lonetti A, Paoloni F, et al: The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome: A report on behalf of the GIMEMA Acute Leukemia Working Party. Haematologica 95:1683-1690, 2010
36. Okamoto R, Ogawa S, Nowak D, et al: Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Haematologica 95:1481-1488, 2010
37. Nahi H, Hägglund H, Ahlgren T, et al: An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: A multi-center study of 381 patients. Haematologica 93:1734-1738, 2008
38. Kim M, Yim SH, Cho NS, et al: Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: A comparative deletion and hypermethylation study. Cancer Genet Cytogenet 195:59-65, 2009
39. Usvasalo A, Savola S, Räty R, et al: CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: An array CGH study. Leuk Res 32:1228-1235, 2008
40. Patel B, Rai L, Buck G, et al: Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: Final results of the international trial UKALL XII/ECOG2993. Br J Haematol 148:80-89, 2010
41. Pulte D, Gondos A, Brenner H: Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113:1408-1411, 2009
42. Harrison CJ: Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 144:147-156, 2009